Perception of gastroesophageal reflux disease in urban population in Pakistan

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 9, 2005, Pages 532-534

  Jafri, Nadim ^a   Jafri, Wasim ^a   Yakoob, Javed ^a   Islam, Muhammad ^a   Manzoor, Shahid ^a   Jalil, Asif ^a   Hashmi, Faraz ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Gastroesophageal; GERB reflux; Health seeking behavior; Urban population

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; ATTITUDE; CONSULTATION; FEMALE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HEALTH BEHAVIOR; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POSTPRANDIAL STATE; QUESTIONNAIRE; SCREENING; SELF MEDICATION; SYMPTOMATOLOGY; TASTE DISORDER; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PATIENT ACCEPTANCE OF HEALTH CARE; URBAN HEALTH;

EID: 27544481625     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Mason RJ. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 1999; 134: 882-8.
2. Hague M, With JW, Stake NH, Talley NJ, Green R. Prevalence, severity and associated features of gastroesophageal reflux and dyspepsia: a population based study: NZ Med J 2000; 113: 178-81.
3. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
4. Johanessen T, Petersen H, Kleveland PM, Dybdahl JH, Sandvik AK, Brenna E, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 687-9.
5. Berstad A, Hatlebakk JG. The predictive value of symptoms in gastroesophageal reflux disease. Scand J Gastroenterol 1995; 211(suppl): 1-4.
6. Gallup. A Gallup Organization National Survey. Heartburn across America. Princeton: The Gallup Organization Inc, 1988.
7. Locke GR, Talley NJ, Fett SL, Zinmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux. A population-based study in Olmsted County, Minnesota: Gastroenterology 1997; 112: 1448-56.
8. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004; 19: 357-67.
9. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000; 15: 230-8.
10. Dent J, Brun J, Fredrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management. The General Workshop Report. Gut 1999; 44(suppl 2): S1-S16.
11. Abid S. Diabetes and esophageal motility disorders: need for clinical relevance. J Pak Med Assoc 2004; 54: 596-7.
12. Ahmed WU, Vohra EA. Normal oesophageal manometric values in healthy adult volunteers. J Pak Med Assoc 2003; 53: 401-5.
13. Http://www.acg.gi.org/patientinfo/gerd/acidtest.html 2005, American College of Gastroenterology.
14. Richter JE. Long-term management of gastroesophageal reflux disease and its complications. Am J Gastroenterol 1997; 92(suppl 4): S30-35.
15. Fass R. Focused clinical review: non-erosive reflux disease. Medscape Gastroenterol 2001; 3: 1-15.
16. Bate CM, Griffin SM, Keeling PW, Axon AT, Dronfield MW, Chapman AW, et al. Reflux symptom relief with omeprazole in patients with unequivocal esophagitis. Aliment Pharmacol Ther 1996; 10: 547-55.
17. Abbas Z, Fareed R, Baig MN, Khan TN, Shah MA. Prevalence of histological reflux esophagitis in H. pylori positive patients: effect of density of H. pylori and activity of inflammation. J Pak Med Assoc 2001; 51: 36-41.
18. Ahmed WU, Vohra EA. Esophageal motility disorders in diabetics. J Pak Med Assoc 2004; 54: 597-601.
19. Salih M, Abid S, Hamid SS, Shah SHA, Abbas Z, Jafri SMW. Carcinoma of the esophagus. Are we different? J Coll Physicians Surg Pak 2005; 15: 313-4.
20. Jafri W, Abbas Z, Hamid S, Abid S, Shah H, Khan H. Omeprazole in short-term treatment of reflux esophagitis. J Pak Med Assoc 1992; 42: 290-92.
21. Ahmed W, Qureshi H, Alam SE, Zuberi SJ. Famotidine 40mg B.I.D. in the treatment of reflux esophagitis. J Pak Med Assoc 1995; 45: 241-3.
22. Orr WC, Robinson MG, Humphries TJ, Antonello J, Cagliola A. Dose-response effect of famotidine on patterns of gastrooesophageal reflux. Aliment Pharmacol Ther 1988; 2: 229-35..
23. Goh K. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol 2004; 19(suppl 3): S22-S25.